Flowable Hemostatic Paste for Minimally Invasive Surgery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing hemostatic compositions face challenges in achieving ease of application, especially in difficult-to-reach areas during surgical procedures, and there is a need for improved formulations that maintain hemostatic functionality without compromising consistency and adhesiveness.

Innovation Solution

A flowable hemostatic composition comprising a blend of oxidized cellulose, fibrinogen, and thrombin, dispersed in a dispersant such as glycerol and an aqueous solution, which forms a porous matrix upon application, facilitating effective hemostasis in hard-to-reach areas.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If sheets are used for hemostasis, then hemostatic performance is improved, but ease of application in minimal invasive surgeries deteriorates

Engineering Contradiction:
Improvehemostatic performanceVSAvoidease of application
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The invention changes the physical state parameter of the hemostatic agent from solid sheet form to flowable paste form. This allows the material to be easily applied in minimally invasive surgeries while maintaining hemostatic performance through the inclusion of oxidized cellulose, fibrinogen, and thrombin in a controlled viscosity range (10-10,000 cP)

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite material system combining oxidized cellulose (for hemostatic and adhesion barrier properties), fibrinogen, and thrombin (for clot formation), dispersed in a carrier fluid. This composite approach maintains the therapeutic effectiveness of sheet-based hemostats while achieving the flowability needed for minimally invasive application

Inventive Principle:
Principle #40Composite materials

2Strength

If viscosity of hemostatic composition is increased, then adhesiveness is improved, but ease of application in hard-to-reach areas deteriorates

Engineering Contradiction:
ImproveadhesivenessVSAvoidease of application
Core Design Contradiction:
StrengthVSEase of operation

Solution Approach 1:

The invention optimizes the viscosity parameter to a specific range (10-10,000 cP) that balances adhesiveness and flowability. This allows the composition to adhere to bleeding surfaces while remaining sufficiently fluid for application in hard-to-reach areas during minimally invasive surgeries

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition provides a stable, easy-to-apply paste that accelerates clot formation and adheres to bleeding sites, effectively controlling bleeding in minimally invasive surgeries by forming a porous matrix that allows blood to percolate and promotes platelet and red cell adhesion.

Implementation Method 1

A flowable hemostatic composition comprising a blend of oxidized cellulose, fibrinogen, and thrombin, dispersed in a dispersant such as glycerol and an aqueous solution

Methodology Applied
Scientific EffectDispersion: Dispersion (of waves)

Implementation Method 2

forming a porous matrix that allows blood to percolate and promotes platelet and red cell adhesion

Methodology Applied
Scientific EffectPorosity: Porosity

Implementation Method 3

a blend of fibrinogen, thrombin, and a dispersant... accelerates clot formation

Methodology Applied
Scientific EffectCoagulation: Coagulation

Data Source

PatentEP4323027B1Flowable hemostatic paste
Publication Date: 2025.11.12 GUANGZHOU BIOSEAL BIOTECH
  • EP4323027B1 patent drawingFigure 1~2
  • EP4323027B1 patent drawingFigure 3A~3B
  • EP4323027B1 patent drawingFigure 3C~3D

AI summary

Disclosed herein are two-component flowable compositions comprised of: (i) a powder of: oxidized cellulose, fibrinogen and thrombin, with the weight ratio of the oxidized cellulose to the fibrinogen ranging from about 1: 5 to about 2: 1, respectively; and (ii) a dispersant comprised of glycerol and an aqueous solution, the composition being in the form of a pasty suspension at a room temperature. Also disclosed are uses of the compositions for treating a bleeding tissue, and methods for making the compositions.